Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

JAMA

Volumn 278, Issue 16, 1997, Pages 1363-1371

  Small, Gary W ^a   Rabins, Peter V ^b   Barry, Patricia P ^b   Buckholtz, Neil S ^b   DeKosky, Steven T ^b   Ferris, Steven H ^b   Finkel, Sanford I ^b   Gwyther, Lisa P ^b   Khachaturian, Zaven S ^b   Lebowitz, Barry D ^b   McRae, Thomas D ^b   Morris, John C ^b   Oakley, Frances ^b   Schneider, Lon S ^b   Streim, Joel E ^b   Sunderland, Trey ^b   Teri, Linda A ^b   Tune, Larry E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTROGEN; GINKGO BILOBA EXTRACT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TACRINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGITATION; ALZHEIMER DISEASE; BEHAVIOR DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; CONFERENCE PAPER; DEMENTIA; DEPRESSION; HEALTH CARE ACCESS; HUMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; RISK FACTOR;

EID: 0030801772     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.16.1363     Document Type: Conference Paper

References (86)

1. Advisory Panel on Alzheimer's Disease. Alzheimer's Disease and Related Dementias: Acute and Long-term Care Services. Washington, DC: US Dept of Health and Human Services; 1996. NIH publication. 96-4136.
2. Evans DA. Estimated prevalence of Alzheimer's disease in the US. Milbank Q. 1990;68:267-289.
3. American Academy of Neurology. Practice parameter for diagnosis and evaluation of dementia (summary statement): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994;44:2203-2206.
4. Costa PT Jr, Williams TF, Somerfield M, et al. Recognition and Initial Assessment of Alzheimer's Disease & Related Dementias. Rockville, Md: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; November 1996. AHCPR publication 97-0702.
5. US Dept of Veterans Affairs, University Health-System Consortium. Dementia Identification and Assessment: Guidelines for Primary Care Practitioners. Oak Brook, Ill: University HealthSystem Consortium; 1997.
6. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons is higher than previously reported. JAMA. 1989;262:2551-2556.
7. Dartigues JF, Gagnon M, Michel P, et al. The Paquid research program on the epidemiology of dementia: methods and initial results. Rev Neurol (Paris). 1991;147:225-230.
8. Heeren TJ, Lagaay AM, Hijmans W, Rooymans HG. Prevalence of dementia in the 'oldest old' of a Dutch community. J Am Geriatr Soc. 1991;35:755-759.
9. Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry. 1995;152:1485-1492.
10. Ritchie K, Kildea D. Is senile dementia 'age related' or 'aging related'? evidence from a meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346:931-934.
11. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993;43:515-519.
12. Jorm AF. The Epidemiology of Alzheimer's Disease and Related Disorders. London, England: Chapman & Hall; 1990.
13. Barrett JJ, Haley WE, Harrell LE, Powers RE. Knowledge about Alzheimer disease among primary care physicians, psychologists, nurses, and social workers. Alzheimer Dis Assoc Disord. 1997;11: 99-106.
14. Hoffman RS. Diagnostic errors in the evaluation of behavioral disorders. JAMA. 1982;248:964-967.
15. McDaniel LD, Lukovits T, McDaniel KD. Alzheimer's disease: the problem of incorrect clinical diagnosis. J Geriatr Psychiatry Neurol. 1993;6:230-234.
16. Ryan DH. Misdiagnosis in dementia: comparisons of diagnostic error rate and range of hospital investigation according to medical specialty. Int J Geriatr Psychiatry. 1994;9:141-147.
17. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med. 1995;122:422-429.
18. Ross GW, Abbott RD, Petrovich H, et al. Frequency and characteristics of silent dementia among elderly Japanese-American men: the Honolulu-Asia Aging Study. JAMA. 1997;277:800-805.
19. McCartney JR, Palmateer LM. Assessment of cognitive deficit in geriatric patients: a study of physician behavior. J Am Geriatr Soc. 1985;33:467-471.
20. German PS, Shapiro S, Skinner EA, et al. Detection and management of mental health problems of older patients by primary care providers. JAMA. 1987;257:489-493.
21. Pinholt EM, Kroenke K, Hanley JF, et al. Functional assessment of the elderly: a comparison of standard instruments with clinical judgments. Arch Intern Med. 1987;147:484-488.
22. Mant A, Eyland EA, Pond DC, Saunders NA, Chancellor AH. Recognition of dementia in general practice: comparison of general practitioners' opinions with assessments using the Mini-Mental State Examination and Blessed dementia rating scale. Fam Pract. 1988;5:184-188.
23. Mohs RC, Breitner JCS, Silverman JM, Davis KL. Alzheimer's disease: a morbid risk among first-degree relatives approximates 50 percent by 90 years of age. Arch Gen Psychiatry. 1987;44:405-408.
24. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology. 1988;38: 307-312.
25. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-706.
26. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
27. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375: 754-760.
28. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
29. American College of Medical Genetics/American Society of Human Genetics Working Group on APOE and Alzheimer's Disease. Statement on the use of apolipoprotein E testing for Alzheimer's disease. JAMA. 1995;274:1627-1629.
30. Relkin NR, Tanzi R, Breitner J, et al. Apolipoprotein E genotyping in Alzheimer's disease: position statement of the National Institute on Aging/ Alzheimer's Association Working Group. Lancet. 1996;347:1091-1095.
31. Stephenson J. Researchers find evidence of a new gene for late-onset Alzheimer disease. JAMA. 1997;277:775.
32. National Institute on Aging. Progress Report on Alzheimer's Disease 1996. Bethesda, Md: National Institute on Aging; 1996. NIH publication 96-4137.
33. Ernst RL, Hay JW. The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health. 1994;84:1261-1264.
34. Schulz R, O'Brien AT, Bookwala J, Fleissner K. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist. 1995;35:771-791.
35. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MS. The role of cost-effectiveness analysis in health and medicine: Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1172-1177.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
37. McKeith LG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
38. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130-135.
39. Stern Y, Alpert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission and death in Alzheimer's disease: prospective analysis from the Predictors Study. Neurology. 1994;44:2300-2307.
40. Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP. Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord. 1997;11:16-20.
41. Francis J, Kapoor WN. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc. 1992;40:601-606.
42. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with 'reversible dementia': a controlled study. Am J Psychiatry. 1993;150:1693-1699.
43. Rasmusson DX, Brandt J, Steele C, et al. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer neuropathology. Alzheimer Dis Assoc Disord. 1996;10: 180-188.
44. Larson EB, Edwards JK, O'Meara E, Nochlin D, Sumi SM. Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia. J Gerontol. 1996;51:M313-M318.
45. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37: 323-329.
46. Teri L, Truax P, Logsdon R, Uomoto J, Zarit S, Vitaliano PP. Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. Psychol Aging. 1992;7:622-631.
47. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
48. Herholz K, Adams R, Kessler J, et al. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia. 1990;1:156-164.
49. Kippenhan JS, Barker WW, Pascal S, Nagel J, Duara R. Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. J Nucl Med. 1992;33:1459-1467.
50. Brust JC. Vascular dementia: still overdiagnosed. Stroke. 1983;14:298-300.
51. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
52. Arnold SE, Kumar A. Reversible dementias. Med Clin North Am. 1993;77:215-230.
53. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease: the Tacrine Study Group. JAMA. 1994;271:985-991.
54. Rogers SL, Friedhof LT, Apter JT, et al. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia. 1996;7:293-303.
55. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol. 1996;9:1-6.
56. Knopman D, Schneider LS, Davis K, et al. Long-term tacrine (Cognex) treatment effects on nursing home placement and mortality: the Tacrine Study Group. Neurology. 1996;47:166-177.
57. Schneider LS. Clinical pharmacology of amino-acridines in Alzheimer's disease. Neurology. 1993; 43(suppl 14):S64-S79.
58. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA. 1994;271:992-998.
59. Cognex (tacrine) [package insert]. Morris Plains, NJ: Warner-Lambert Co; 1996.
60. Aricept (donepezil) [package insert]. New York, NY: Pfizer Inc; 1997.
61. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336:1216-1222.
62. Baines S, Saxby P, Ehlert K. Reality orientation and reminiscence therapy: a controlled cross-over study of elderly confused people. Br J Psychiatry. 1987;151:222-231.
63. Woods P, Ashley J. Simulated presence therapy: using selected memories to manage problem behaviors in Alzheimer's disease patients. Geriatr Nurs. 1995;16:9-14.
64. Logsdon RG, Teri L. The Pleasant Events Schedule-AD: psychometric properties of long and short forms and an investigation of its association to depression and cognition in Alzheimer's disease patients. Gerontologist. 1997;37:40-45.
65. Meyers K, Griggin M. The Play Project: use of stimulus objects with demented patients. J Gerontol Nurs. 1990;16:32-37.
66. Mintzer JE, Lewis L, Pennypaker L, et al. Behavioral intensive care unit (BICU): a new concept in the management of acute agitated behavior in elderly demented patients. Gerontologist. 1993;33:801-806.
67. Teri L, Uomoto J. Reducing excess disability in dementia patients: training caregivers to manage patient depression. Clin Gerontol. 1991;10:49-63.
68. Teri L, Logsdon R, Uomoto J, et al. Treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci. 1997;52: 159-166.
69. Patterson MB, Bolger JP. Assessment of behavioral symptoms in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994;8(suppl 3):4-20.
70. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;28:553-563.
71. Rada RT, Kellner R. Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome. J Am Geriatr Soc. 1976;24:105-107.
72. Madhusoodanan S, Brenner R, Arujo L, et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry. 1995;56:514-518.
73. Salzman C, Vaccaro B, Lieff J, et al. Clozapine in older patients with psychosis and behavioral disturbances. Am J Geriatr Psychiatry. 1995;3:26-33.
74. Chacko R, Hurley R, Jankovic J. Clozapine use in diffuse Lewy body disease. J Neuropsychiatry Clin Neurosci. 1993;5:206-208.
75. Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris MJ. Management of late-life psychosis. J Clin Psychiatry. 1996;57(suppl 3):39-45.
76. Grad R. Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. J Fam Pract. 1995;41:473-481.
77. Tariot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc. 1994;42:1160-1166.
78. Mellow AM, Solano-Lopez C, Davis S. Sodium valproate in the treatment of behavioral disturbance in dementia. J Geriatr Psychiatry Neurol. 1993;6: 205-209.
79. Sultzer DL, Gray KF, Gunay I, et al. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry. 1997;5:60-69.
80. Sakauye KM, Camp CJ, Ford PA. Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry. 1993;1:894-901.
81. Nyth AL, Gottfries CG, Lyby K, et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concommitant dementia. Acta PsychiatrScand. 1992;86:138-145.
82. Overman W Jr, Stoudemire A. Guidelines for legal and financial counseling of Alzheimer's disease patients and their families. Am J Psychiatry. 1988; 145:1495-1500.
83. Cohen-Mansfield J, Rabinovich BA, Lipson S, et al. The decision to execute a durable power of attorney for healthcare and preferences regarding the utilization of life sustaining treatments in nursing home patients. Arch Intern Med. 1991;151:289-294.
84. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer's disease: a randomized, controlled trial. JAMA. 1996; 276:1725-1731.
85. Gwyther LP, Rabins PV. Practical approaches for treating behavioral symptoms of people with mild to moderate Alzheimer's disease. Prim Psychiatry. 1996;3:27-38.
86. Fitten LJ, Perryman KM, Wilkinson CJ, Little RJ, Burns MM, Pachana N. Alzheimer and vascular dementias and driving: a prospective road and laboratory study. JAMA. 1995;273:1360-1365.